Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Shares Outstanding (Diluted Average): 2021-2024

Historic Shares Outstanding (Diluted Average) for Caribou Biosciences (CRBU) over the last 4 years, with Dec 2024 value amounting to $90.3 million.

  • Caribou Biosciences' Shares Outstanding (Diluted Average) rose 3.14% to $93.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.3 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of $90.3 million for FY2024, which is 22.37% up from last year.
  • Caribou Biosciences' Shares Outstanding (Diluted Average) amounted to $90.3 million in FY2024, which was up 22.37% from $73.8 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Shares Outstanding (Diluted Average) ranged from a high of $90.3 million in FY2024 and a low of $31.7 million during FY2021.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $73.8 million (2023), whereas its average is $75.0 million.
  • Data for Caribou Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY surged of 92.02% (in 2022) over the last 5 years.
  • Over the past 4 years, Caribou Biosciences' Shares Outstanding (Diluted Average) (Yearly) stood at $31.7 million in 2021, then spiked by 92.02% to $60.8 million in 2022, then rose by 21.39% to $73.8 million in 2023, then increased by 22.37% to $90.3 million in 2024.